...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >PRELIMINARY PHYTOCHEMICAL SCREENING AND ANTIBACTERIAL ACTIVITY OF LAWSONIA INERMIS LINN (HENNA) LEAF EXTRACTS AGAINST REFERENCE BACTERIAL STRAINS AND CLINICALLY IMPORTANT AMPC ΒETA-LACTAMASES PRODUCING PROTEUS MIRABILIS
【24h】

PRELIMINARY PHYTOCHEMICAL SCREENING AND ANTIBACTERIAL ACTIVITY OF LAWSONIA INERMIS LINN (HENNA) LEAF EXTRACTS AGAINST REFERENCE BACTERIAL STRAINS AND CLINICALLY IMPORTANT AMPC ΒETA-LACTAMASES PRODUCING PROTEUS MIRABILIS

机译:劳森氏菌InerMIS Linn(henna)叶提取物针对参考细菌菌株和临床上重要的AMPCΒ-乳糖酶产生蛋白变形菌的初步理化筛选和抗菌活性

获取原文

摘要

Phytochemical screening and antibacterial activity o f aqueous, ethanol, methanol, ethyl acetate and chloroform extracts of Lawsonia inermis Linn leaves were tested against reference bacterial strains (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeuroginosa, Proteus mirabilis, Salmonella typhi, Vibrio cholerae, Staphylococcus aureus, Methicillin Resistant Staphylococcus aureus) and clinical isolates (Staphylococcus aureus and AmpC β-lactamases producing Proteus mirabilis). The solvent extracts of L. inermis leaves exhibited profound antibacterial activity against the bacterial pathogens tested. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the extracts for Gram positive species were between 34-64 μg and 39-74 μg . MIC and MBC of the extracts for Gram negative species were between 46-71 μg and 51-75 μg. The role of the plant material was apparent in inhibiting the growth of clinically important AmpC β-lactamases producing Proteus mirabilis, which have developed resistance to commonly prescribed antibiotics used for treating infections caused by uropathogens. The findings of the present study may emphasize the use of L. inermis leaf extracts with antibiotics for restricting the growth of clinically important multi-drug resistant uropathogens
机译:测试了无毛劳氏亚麻叶片的水,乙醇,甲醇,乙酸乙酯和氯仿提取物的​​植物化学筛选和抗菌活性,以针对参考细菌菌株(大肠杆菌,肺炎克雷伯菌,假单胞菌,变形杆菌,鼠伤寒沙门氏菌,霍乱弧菌,葡萄球菌)进行了测试耐甲氧西林金黄色葡萄球菌)和临床分离株(金黄色葡萄球菌和AmpCβ-内酰胺酶产生奇异变形杆菌)。无定形乳杆菌叶的溶剂提取物对测试的细菌病原体表现出深厚的抗菌活性。提取物对革兰氏阳性菌的最低抑菌浓度(MIC)和最低杀菌浓度(MBC)在34-64μg至39-74μg之间。革兰氏阴性菌提取物的MIC和MBC在46-71μg和51-75μg之间。该植物材料在抑制临床上重要的AmpCβ-内酰胺酶(产生奇异变形杆菌)的生长中的作用是显而易见的,这些蛋白对通常用于治疗尿毒症引起的感染的处方抗生素产生了抗药性。本研究的结果可能会强调使用无水乳杆菌叶提取物和抗生素来限制临床上重要的多药耐药性尿路致病菌的生长

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号